Aclaris Therapeutics Inc (ACRS)
1.23
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
1.22
-0.01
(-0.81%)
After-Hours: 05:07
Aclaris Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0459 |
| March 31, 2021 | 0.0952 |
| December 31, 2020 | 0.2829 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.2604 |
| June 30, 2020 | 0.2142 |
| March 31, 2020 | 0.1817 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.351 |
| June 30, 2019 | 0.2181 |
| March 31, 2019 | 0.1642 |
| December 31, 2018 | 0.1391 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.351
Maximum
Sep 2019
0.0868
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Aldeyra Therapeutics Inc | -- |
| Allakos Inc | -- |
| Regeneron Pharmaceuticals Inc | 0.0763 |
| Puma Biotechnology Inc | 1.865 |
| CytomX Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 197.40M |
| Total Liabilities (Quarterly) | 40.23M |
| Shareholders Equity (Quarterly) | 157.18M |
| Current Ratio | 4.163 |